These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 36813082)
21. An Overview of the Pharmacological Properties of Calebin-A. Shamsnia H; Samanian A; Sabbagh Kashani A; Khayatan D; Momtaz S; Johnston TP; Majeed M; Jamialahmadi T; Abdolghaffari AH; Sahebkar A Curr Med Chem; 2023 Oct; ():. PubMed ID: 37817661 [TBL] [Abstract][Full Text] [Related]
22. Targeting NF-κB Signaling by Calebin A, a Compound of Turmeric, in Multicellular Tumor Microenvironment: Potential Role of Apoptosis Induction in CRC Cells. Buhrmann C; Shayan P; Banik K; Kunnumakkara AB; Kubatka P; Koklesova L; Shakibaei M Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32708030 [TBL] [Abstract][Full Text] [Related]
23. Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116. Kukcinaviciute E; Jonusiene V; Sasnauskiene A; Dabkeviciene D; Eidenaite E; Laurinavicius A J Cell Biochem; 2018 Jul; 119(7):5913-5920. PubMed ID: 29637602 [TBL] [Abstract][Full Text] [Related]
24. The E3 ubiquitin ligase NEDD4 regulates chemoresistance to 5-fluorouracil in colorectal cancer cells by altering JNK signalling. Anand S; Nedeva C; Chitti SV; Fonseka P; Kang T; Gangoda L; Tabassum NI; Abdirahman S; Arumugam TV; Putoczki TL; Kumar S; Mathivanan S Cell Death Dis; 2023 Dec; 14(12):828. PubMed ID: 38097550 [TBL] [Abstract][Full Text] [Related]
25. Oxaliplatin and irinotecan induce heterogenous changes in the EMT markers of metastasizing colorectal carcinoma cells. Skarkova V; Kralova V; Krbal L; Matouskova P; Soukup J; Rudolf E Exp Cell Res; 2018 Aug; 369(2):295-303. PubMed ID: 29842879 [TBL] [Abstract][Full Text] [Related]
26. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX. Hu J; Cai G; Xu Y; Cai S Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693 [TBL] [Abstract][Full Text] [Related]
27. Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo. Li M; Yue GG; Tsui SK; Fung KP; Lau CB Phytomedicine; 2018 Jul; 46():131-141. PubMed ID: 30097113 [TBL] [Abstract][Full Text] [Related]
28. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells. Genovese S; Epifano F; Preziuso F; Slater J; Nangia-Makker P; Majumdar APN; Fiorito S Biochem Biophys Res Commun; 2020 Jan; 522(1):95-99. PubMed ID: 31740005 [TBL] [Abstract][Full Text] [Related]
29. Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo. Jeng LB; Kumar Velmurugan B; Chen MC; Hsu HH; Ho TJ; Day CH; Lin YM; Padma VV; Tu CC; Huang CY J Cell Physiol; 2018 Sep; 233(9):7134-7142. PubMed ID: 29574877 [TBL] [Abstract][Full Text] [Related]
30. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659 [TBL] [Abstract][Full Text] [Related]
31. Curcumin cytotoxicity is enhanced by PTEN disruption in colorectal cancer cells. Chen L; Li WF; Wang HX; Zhao HN; Tang JJ; Wu CJ; Lu LT; Liao WQ; Lu XC World J Gastroenterol; 2013 Oct; 19(40):6814-24. PubMed ID: 24187456 [TBL] [Abstract][Full Text] [Related]
32. Patient-derived Organoid Model for Predicting the Chemoresponse in Patients With Colorectal Cancer. Yi K; Park SH; Kim DU; Jeon DY; Lee HJ; Song GA; Jo HJ; Baek DH; Han JH; Lee BC In Vivo; 2023; 37(4):1751-1759. PubMed ID: 37369516 [TBL] [Abstract][Full Text] [Related]
33. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498 [TBL] [Abstract][Full Text] [Related]
34. A comprehensive update on the potential of curcumin to enhance chemosensitivity in colorectal cancer. Shadnoush M; Momenan M; Seidel V; Tierling S; Fatemi N; Nazemalhosseini-Mojarad E; Norooz MT; Cheraghpour M Pharmacol Rep; 2024 Sep; ():. PubMed ID: 39304638 [TBL] [Abstract][Full Text] [Related]
35. Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment. Brockmueller A; Girisa S; Kunnumakkara AB; Shakibaei M Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902421 [TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer. Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714 [TBL] [Abstract][Full Text] [Related]
37. Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells. Schulze-Bergkamen H; Ehrenberg R; Hickmann L; Vick B; Urbanik T; Schimanski CC; Berger MR; Schad A; Weber A; Heeger S; Galle PR; Moehler M World J Gastroenterol; 2008 Jun; 14(24):3829-40. PubMed ID: 18609706 [TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling. Wang D; Yang L; Yu W; Wu Q; Lian J; Li F; Liu S; Li A; He Z; Liu J; Sun Z; Yuan W; Zhang Y J Immunother Cancer; 2019 Aug; 7(1):215. PubMed ID: 31395078 [TBL] [Abstract][Full Text] [Related]
39. Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell lines. Skarkova V; Skarka A; Manethova M; Stefanidi AA; Rudolf E Hum Exp Toxicol; 2021 Dec; 40(12):2063-2073. PubMed ID: 34075792 [TBL] [Abstract][Full Text] [Related]
40. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin. Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]